Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
11.71
+0.31 (2.72%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 35 employees as of December 31, 2025. The number of employees increased by 3 or 9.38% compared to the previous year.
Employees
35
Change (1Y)
3
Growth (1Y)
9.38%
Revenue / Employee
$1,692,029
Profits / Employee
-$92,857
Market Cap
410.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | 3 | 9.38% |
| Dec 31, 2024 | 32 | 3 | 10.34% |
| Dec 31, 2023 | 29 | -7 | -19.44% |
| Dec 31, 2022 | 36 | 26 | 260.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Rocket Pharmaceuticals | 202 |
| Enanta Pharmaceuticals | 120 |
| Foghorn Therapeutics | 106 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 63 |
FENC News
- 8 days ago - Fennec price target raised to $16 from $13 at Wedbush - TheFly
- 8 days ago - Fennec price target raised to $18 from $16 at B. Riley - TheFly
- 14 days ago - Fennec Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Fennec Pharmaceuticals Earnings release: Q2 2026 - Filings
- 14 days ago - Fennec Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 20 days ago - Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026 - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Fennec Announces Results of Annual Meeting - GlobeNewsWire